Marketing Strategy Of Drugs For Chronic Diseases

China’s large population, the rapid economic development, drive the medical market annual double-digit rapid development, since the reform and opening up, foreign drug companies with a unique identity well in China’s development. As a new round of healthcare reform formally launched, great changes have taken place in the medical environment in China, foreign pharmaceutical market growth slows down gradually. Due to the United States and Western Europe and other developed countries to improve and severe overseas anti-corruption law and the relevant institutional constraints and foreign pharmaceutical enterprises in China has been to academic promotion as the main line, the world’s top 100 pharmaceutical enterprises in the areas of chronic disease and drug occupy absolute advantage. Including Pfizer has been foreign drug companies, its lipitor sales promotion in China is a classic in the field of foreign drug firms slow disease, also represents the vast majority of foreign drug firms slow disease drug promotion process. Products from entering the market to mature period, after the patent period of marketing strategy, represents the type of enterprise development in this field. So, for example, through the analysis of the marketing strategy of lipitor to explore foreign slow disease drug marketing strategy is particularly important in China. With the change of medical environment and the market competition intensifying, effective marketing strategy began to failure before, have to make marketing strategy to explore and analysis, find out the problem.In this paper, through theoretical analysis, field research, policy, study methods, such as using the STP and 4 ps tools to lipitor the product marketing strategy recommendations. Suggestions for product positioning to lipitor is clear and stable, the price can be reduced to preempt the secondary market, adding more supply channels and good management, routine work, the core of medical information needs a higher level of medical communication experts, strengthen on patient education promotion.